SpringWorks Therapeutics - Stock Price History | SWTX
Historical daily share price chart and data for SpringWorks Therapeutics since 2022 adjusted for splits. The latest closing stock price for SpringWorks Therapeutics as of May 23, 2022 is 38.00.
- The all-time high SpringWorks Therapeutics stock closing price was 93.59 on February 24, 2021.
- The SpringWorks Therapeutics 52-week high stock price is 89.75, which is 136.2% above the current share price.
- The SpringWorks Therapeutics 52-week low stock price is 33.33, which is 12.3% below the current share price.
- The average SpringWorks Therapeutics stock price for the last 52 weeks is 65.42.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| SpringWorks Therapeutics Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2021 |
74.3153 |
68.9700 |
93.5900 |
53.3000 |
61.9800 |
-14.53% |
| 2020 |
43.9053 |
35.1600 |
77.9200 |
20.4400 |
72.5200 |
88.41% |
| 2019 |
23.4396 |
22.6300 |
39.5200 |
17.7400 |
38.4900 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.838B |
$0.035B |
|
SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc. is based in Stamford, United States.
|
